AI Detection for Medical Writers: Regulatory Submissions, CME Content, and AI Scrutiny

Medical writers live with a kind of scrutiny most content people never face. A misplaced claim in a clinical study report or a CME module isn’t a typo—it’s a regulatory and patient-safety problem. So when AI drafting tools showed up in this field, two very different watchers showed up with them: the statistical AI detectors that scan for machine patterns, and the human reviewers who actually decide whether your work is trustworthy.

Here’s the thing worth getting straight early: those two audiences care about completely different things. Understanding the gap is the whole job.

Key takeaways

• Medical writing faces scrutiny from both AI detectors (which flag statistical patterns) and human reviewers—regulators, editors, CME accreditors—who care about provenance and accountability.
• Agencies like the FDA and EMA haven’t banned AI from document preparation; they require a qualified human to take responsibility for accuracy. An AI-detection score is irrelevant to that.
• The plain, standardized house style medical writing demands is exactly the low-perplexity prose detectors flag, so false positives are a genuine occupational hazard.
• Detectors output probabilities, not proof. OpenAI retired its own classifier in July 2023, and a 2023 Stanford study found detectors biased against non-native English writers.
• The defensible workflow is documentation—keep sources, drafts, and a record of where AI helped and how you verified it. Chasing a detector score is the wrong target.

Two audiences, two definitions of “passing”

When a marketer worries about AI detection, they usually mean a single number: does this clear Originality.ai or GPTZero? In medical writing, that framing is almost a trap, because the people who matter most aren’t using those tools at all.

A regulatory reviewer at the FDA or EMA is reading your submission to answer one question: can a qualified, accountable human vouch that this is accurate and traceable to source data? They don’t run your clinical study report through a detector. They check whether your efficacy numbers match the statistical analysis plan output, whether adverse events are reported correctly, whether claims are supported by the underlying tables. Provenance, not prose style.

The detector, meanwhile, doesn’t know or care whether your sentence is true. It’s measuring how statistically predictable your text is—essentially perplexity and burstiness—the statistics most detectors run on. That’s a different question entirely, and confusing the two is where medical writers get into trouble.

Why regulatory and CME writing trips detectors

Good medical writing is supposed to be predictable. That’s not a flaw—it’s the requirement.

Clinical study reports follow ICH E3 structure. Submissions follow controlled vocabularies and standardized headings. CME content is built to learning objectives and reviewed for balance. You’re rewarded for using the same term the same way every time, for short unambiguous sentences, for stripping out the very stylistic flourishes that make text “bursty.” Ambiguity is a defect here, not a virtue.

The problem? Low ambiguity, controlled vocabulary, and steady sentence rhythm produce low perplexity and flat burstiness—the exact statistical fingerprint detectors associate with machine generation. So a meticulous human-written CSR section can score as “likely AI” precisely because it’s well-written for its purpose.

This isn’t hypothetical bias, either. A 2023 Stanford study (Liang et al.) found that AI detectors disproportionately flag non-native English writers, whose prose tends toward simpler, more uniform constructions. Medical writing teams are heavily international. The same mechanism that penalizes an ESL writer penalizes a writer following a rigid style guide.

A mini-scenario

A regulatory writer in Pune drafts the safety narrative section of a CSR. English is her second language, the section follows a locked template, and the terminology is dictated by the protocol. Her CRO runs new drafts through an AI detector as part of a QC checklist someone added last quarter. Her section comes back flagged as overwhelmingly “AI-generated.”

She didn’t use AI. The detector flagged her for writing exactly the way the document demands—plain, uniform, controlled. If that score is treated as evidence rather than a prompt to look closer, she’s now defending her own competent work against a number that was never designed to judge it.

What regulators and accreditors actually expect

Let’s be precise, because vague fear helps no one.

The FDA issued draft guidance in January 2025 on using AI to support regulatory decision-making for drugs and biologics. The throughline is risk-based credibility: AI is a tool, and a responsible human still owns the output. Nothing in it says “don’t use AI to draft documents.” It says be able to justify and verify what you produce.

The EMA has published a reflection paper on AI across the medicinal product lifecycle with a similar stance—transparency, human oversight, and accountability rather than prohibition.

The ICMJE (which most major medical journals follow) asks authors to disclose AI-assisted technologies used in producing a manuscript and is explicit that AI cannot be an author, because it can’t be responsible for the work. Many CME accreditors have adopted comparable disclosure expectations.

Notice what’s missing from all of these: any requirement to hit a particular AI-detection score. The standard is accountability and accuracy, full stop. A document can be partly AI-assisted and fully compliant. A document can be 100% human and still get rejected if a claim isn’t supported.

The defensible workflow: provenance over scores

If detection scores don’t satisfy regulators, what does? Documentation. The same discipline that already governs good medical writing.

1. Keep your chain of sources. Every claim should trace to a table, a reference, or a dataset. This is your real defense, and it predates AI entirely.
2. Preserve intermediate drafts. Track changes, version history, and outlines show a human shaping the document over time. That record is far more persuasive than any counter-score.
3. Record where and how AI assisted. If a tool drafted a first pass of a background section, note it and note your verification step. This is what disclosure policies are asking for anyway.
4. Verify every fact the AI touched. Language models confidently invent citations and misstate numbers. In this field, an unverified AI claim isn’t a style problem—it’s a fabrication risk. This step is non-negotiable.

If a QC checklist or an editor flags your text as “AI,” you respond with provenance, not a screenshot of a lower score. You walk them through it: this sentence maps to this CSR table, this claim to this reference. That answers the question they actually have.

Where humanizing fits—and where it doesn’t

There’s a legitimate place for cleaning up machine phrasing. If an AI draft reads stiff, repetitive, or oddly generic, smoothing it for clarity is ordinary editorial work. Done honestly, it makes the document better for the human reviewer who matters most.

But keep the line bright. The goal is never to disguise fabricated data, dodge a required disclosure, or make it look like a person did work a machine did so you can skip verification. In medical writing, “sounds human” is a distant second to “is accurate and accountable.” If your editing process improves readability while every fact stays sourced and verified, you’re fine. If it’s a tactic to hide something, the AI score is the least of your problems.

A detection checker earns its keep here in one narrow way: spotting the flat, generic passages that probably also read poorly to a human reviewer. Use it to find the spots worth a real editorial pass—browse more on how AI detection actually works if you want the mechanics.

A quick reality check on the detectors themselves

It helps to remember how shaky these tools are even on their own terms. OpenAI built an AI text classifier and then quietly retired it in July 2023 because its accuracy was too low to be useful. If the company making the models couldn’t reliably detect them, a third-party tool scanning your CSR isn’t delivering a verdict—it’s offering a probability with a meaningful error rate.

That’s the right mental model. A detector gives you a signal. Your sourcing, your drafts, and your sign-off give you a defense. Don’t outsource your credibility to a number that was never built to carry it. For what the plans cover, here are the plans and limits.

Frequently asked questions

The Q&A below covers the questions medical writers ask most—on FDA and EMA expectations, false positives on clinical documents, disclosure under ICMJE and CME rules, defending a flagged document, and the ethics of editing AI-drafted content.

Bottom line

Medical writing has always answered to a higher bar than “does it sound human.” The bar is: is it accurate, sourced, and owned by an accountable person? AI detectors don’t measure any of that, and the regulators and accreditors who decide your work’s fate aren’t using them. Treat scores as a rough signal, keep your provenance airtight, and verify everything a model touches.

If you want to see which sentences in a draft read as flat or machine-generated before a reviewer does, run it through PaperBleach and use the heatmap to guide an honest editorial pass.